Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chubb
Harvard Business School
Queensland Health
QuintilesIMS
Fuji
Julphar
Argus Health
Fish and Richardson

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019386

« Back to Dashboard

NDA 019386 describes BREVIBLOC IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from five suppliers. There are two patents protecting this drug. Additional details are available on the BREVIBLOC IN PLASTIC CONTAINER profile page.

The generic ingredient in BREVIBLOC IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
Summary for 019386
Tradename:BREVIBLOC IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare
Ingredient:esmolol hydrochloride
Patents:2
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 019386
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 019386
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA West Ward Pharmaceutical Corporation 0641-2965 E 0641-2965-45
BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-055 N 10019-055-61

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Aug 15, 1988TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1GM/100ML
Approval Date:Feb 16, 2001TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jul 12, 2021Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Jul 12, 2021Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 019386

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386-003 Aug 15, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386-003 Aug 15, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386-007 May 28, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386-006 Feb 25, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Harvard Business School
Cantor Fitzgerald
Cerilliant
Boehringer Ingelheim
Julphar
Federal Trade Commission
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.